EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zhejiang Nhu Co's enterprise value is ¥67,419 Mil.
Zhejiang Nhu Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ¥8,285 Mil. Therefore, Zhejiang Nhu Co's EV-to-EBITDA for today is 8.14.
The historical rank and industry rank for Zhejiang Nhu Co's EV-to-EBITDA or its related term are showing as below:
SZSE:002001'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.27 Med: 15.78 Max: 38.04
Current: 8.14
During the past 13 years, the highest EV-to-EBITDA of Zhejiang Nhu Co was 38.04. The lowest was 7.27. And the median was 15.78.
SZSE:002001's EV-to-EBITDA is ranked better than 74.34% of 725
companies
in the Drug Manufacturers industry
Industry Median: 14.23
vs SZSE:002001: 8.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Zhejiang Nhu Co EV-to-EBITDA Historical Data
The historical data trend for Zhejiang Nhu Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zhejiang Nhu Co's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Nhu Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Zhejiang Nhu Co's EV-to-EBITDA falls into.
Zhejiang Nhu Co's current Enterprise Value is ¥67,419 Mil.
Zhejiang Nhu Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8,285 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Nhu Co (SZSE:002001) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zhejiang Nhu Co's PE Ratio (TTM) for today is calculated as:
Zhejiang Nhu Co's share price for today is ¥21.77.
Zhejiang Nhu Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Zhejiang Nhu Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002001 has been successfully added to your 